Get started
Author

Daniel W. Drolet

Observed names: D W Drolet, D. Drolet, D. W. Drolet, Daniel W Drolet
Observed institutions: Howard Hughes Medical Institute, Genentech, New Cross Hospital, Belfast City Hospital, University of California San Diego, Nivalis Therapeutics (United States), SomaLogic (United States), State of Colorado, Standard BioTools (United States)
ORCID: 0000-0002-1877-0092
Observed ORCID: 0000-0002-1877-0092
OpenAlex ID: A5102948810
An enzyme-linked oligonucleotide assay
1996 · Daniel W. Drolet, Lotus Moon-McDermott, et al. · Nature Biotechnology · 343
POU-domain proteins: structure and function of developmental regulators
1993 · Michael Wegner, Daniel W. Drolet, et al. · Current Opinion in Cell Biology · 246
TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins.
1991 · D W Drolet, K M Scully, et al. · Genes & Development · 245
Pharmacokinetics and Safety of an Anti-Vascular Endothelial Growth Factor Aptamer (NX1838) Following Injection into the Vitreous Humor of Rhesus Monkeys
2000 · Daniel W. Drolet, Joyce Nelson, et al. · Pharmaceutical Research · 208
Aptamer affinity chromatography:
1999 · Timothy S Romig, Carol Bell, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 202
Pituitary ontogeny of the Snell dwarf mouse reveals Pit-1-independent and Pit-1-dependent origins of the thyrotrope
1994 · Sheng-Cai Lin, Sen Li, et al. · Development · 182
Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys
1999 · Christopher E. Tucker, Long-Shiuh Chen, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 177
Fit for the Eye: Aptamers in Ocular Disorders
2016 · Daniel W. Drolet, Louis S. Green, et al. · Nucleic Acid Therapeutics · 123
PDF
Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy.
1993 · M Wegner, D W Drolet, et al. · Proceedings of the National Academy of Sciences · 90
A High Throughput Platform for Systematic Evolution of Ligands by Exponential Enrichment (SELEX™)
1999 · D. W. Drolet, R. D. Jenison, et al. · Combinatorial Chemistry & High Throughput Screening · 73
An enzyme-linked immunosorbent assay to study human relaxin in human pregnancy and in pregnant rhesus monkeys
1989 · C. Lucas, L. N. Bald, et al. · Journal of Endocrinology · 65
Reduced fertility in mice deficient for the POU protein sperm-1
1997 · Richard V. Pearse, Daniel W. Drolet, et al. · Proceedings of the National Academy of Sciences · 64
Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the Proteome
2024 · Stephan Kraemer, Daniel J. Schneider, et al. · Journal of Proteome Research · 55
PDF
Synergistic interactions between Pit-1 and other elements are required for effective somatotroph rat growth hormone gene expression in transgenic mice
1993 · S A Lira, K A Kalla, et al. · Molecular Endocrinology · 55
PDF
The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects
2014 · Marta Hamilton, Julie L. Wolf, et al. · Cancer Chemotherapy and Pharmacology · 47
Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys
2015 · Masao Hirota, Ikuo Murakami, et al. · Nucleic Acid Therapeutics · 41
PDF
Pharmacokinetic Properties of DNA Aptamers with Base Modifications
2017 · Shashi Gupta, Daniel W. Drolet, et al. · Nucleic Acid Therapeutics · 34
PDF
A nonclinical safety and pharmacokinetic evaluation of N6022: A first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma
2011 · Dorothy B. Colagiovanni, Daniel W. Drolet, et al. · Regulatory Toxicology and Pharmacology · 33
Expression patterns of the hepatic leukemia factor gene in the nervous system of developing and adult mice
1999 · Johann K. Hitzler, Holly D. Soares, et al. · Brain Research · 32
Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture
1990 · Susan Mukavitz Kramer, Ursula E. M. Gibson, et al. · In Vitro Cellular & Developmental Biology - Plant · 26
Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
2019 · Anne M. Lynch, Brandie D. Wagner, et al. · Translational Vision Science & Technology · 25
Phase I, Pharmacokinetic and Biological Correlative Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor, and Cisplatin in Patients with Solid Tumors
2008 · Alejandro D. Ricart, Jordan D. Berlin, et al. · Clinical Cancer Research · 17
Pharmacokinetics, Safety, and Efficacy of a Liposome Encapsulated Thymidylate Synthase Inhibitor, OSI-7904L [(S)-2-[5-[(1,2-Dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric Acid] in Mice
2004 · John Desjardins, David L. Emerson, et al. · Journal of Pharmacology and Experimental Therapeutics · 16
Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B
2021 · Xin Xu, Chi Zhang, et al. · The Journal of Immunology · 15
SOMAmer reagents and the SomaScan platform: Chemically modified aptamers and their applications in therapeutics, diagnostics, and proteomics
2022 · Daniel J. Schneider, Sean A. Lynch, et al. · Elsevier eBooks · 14
Works count: 41
Citation count: 2,495
H-index: 21
I10-index: 27
Year
Topic
Type